NCT06597799View on ClinicalTrials.gov

First-in-human Study of MRT-6160 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

April 10, 2025

Study Completion Date

April 10, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

MRT-6160

Orally administered tablets or capsules of MRT-6160

DRUG

Placebo

Orally administered tablets or capsules of placebo

Trial Locations (2)

68502

Celerion, Lincoln

85283

Celerion, Inc., Tempe

Sponsors
All Listed Sponsors
lead

Monte Rosa Therapeutics, Inc

INDUSTRY

NCT06597799 - First-in-human Study of MRT-6160 in Healthy Subjects | Biotech Hunter | Biotech Hunter